Johanna Seddon to Eye Neoplasms
This is a "connection" page, showing publications Johanna Seddon has written about Eye Neoplasms.
Connection Strength
0.295
-
Little MP, Schaeffer ML, Reulen RC, Abramson DH, Stovall M, Weathers R, de Vathaire F, Diallo I, Seddon JM, Hawkins MM, Tucker MA, Kleinerman RA. Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study. Br J Cancer. 2014 May 13; 110(10):2623-32.
Score: 0.115
-
Seddon JM, Polivogianis L, Gragoudas ES, Hsieh CC, Egan KM. Enucleation vs cobalt 60 irradiation of melanomas. Arch Ophthalmol. 1986 Feb; 104(2):175-6.
Score: 0.065
-
Wong FL, Boice JD, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF, Li FP. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997 Oct 15; 278(15):1262-7.
Score: 0.037
-
Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993 Jul 21; 85(14):1121-8.
Score: 0.027
-
Gamel J, Seddon J, Polivogianis L, Albert D, Greenberg R. A method for assessing potential bias among cancer patients recorded as "dead of other causes." Application to cases of intraocular melanoma. Cancer. 1986 Jun 01; 57(11):2246-9.
Score: 0.017
-
Weinhaus RS, Seddon JM, Albert DM, Gragoudas ES, Robinson N. Prognostic factor study of survival after enucleation for juxtapapillary melanomas. Arch Ophthalmol. 1985 Nov; 103(11):1673-7.
Score: 0.016
-
Albert DM, McGhee CN, Seddon JM, Weichselbaum RR. Development of additional primary tumors after 62 years in the first patient with retinoblastoma cured by radiation therapy. Am J Ophthalmol. 1984 Feb; 97(2):189-96.
Score: 0.014
-
terPenning BJ, Cheng HM, Barnett P, Seddon J, Sang D, Latina M, Aguayo J, Gonz?lez RG, Brady TJ. MR imaging of enucleated human eyes at 1.4 tesla. J Comput Assist Tomogr. 1986 Jul-Aug; 10(4):551-9.
Score: 0.004